Bronchospasm News and Research

RSS
SYNERA can help prevent needle stick pain associated with superficial IVs

SYNERA can help prevent needle stick pain associated with superficial IVs

Kids exposed to cooking or tobacco smoke more likely to suffer excessive pain after tonsillectomies

Kids exposed to cooking or tobacco smoke more likely to suffer excessive pain after tonsillectomies

GSK reports positive results from Incruse Ellipta and Advair Diskus combination therapy in COPD patients

GSK reports positive results from Incruse Ellipta and Advair Diskus combination therapy in COPD patients

Cumberland launches new Vaprisol product

Cumberland launches new Vaprisol product

GSK, Theravance announce availability of Anoro Ellipta in the US for COPD treatment

GSK, Theravance announce availability of Anoro Ellipta in the US for COPD treatment

Genmab/GSK receive FDA sBLA approval for Arzerra in combination with chlorambucil for treatment of CLL

Genmab/GSK receive FDA sBLA approval for Arzerra in combination with chlorambucil for treatment of CLL

FDA approves Xolair for treatment of chronic idiopathic urticaria

FDA approves Xolair for treatment of chronic idiopathic urticaria

Pierre Fabre Dermatologie receives FDA marketing authorization for pediatric drug Hemangeol

Pierre Fabre Dermatologie receives FDA marketing authorization for pediatric drug Hemangeol

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

FDA approves Baxter's FEIBA for prophylactic treatment of hemophilia patients with inhibitors

FDA approves Baxter's FEIBA for prophylactic treatment of hemophilia patients with inhibitors

Call for greater beta blocker use in COPD

Call for greater beta blocker use in COPD

Cumberland Pharmaceuticals net revenue decreases from $12.5 to $6.5 million

Cumberland Pharmaceuticals net revenue decreases from $12.5 to $6.5 million

Once-daily prescription medicine for COPD now available throughout the U.S.

Once-daily prescription medicine for COPD now available throughout the U.S.

Exercise-induced bronchoconstriction (EIB) guidelines: an interview with Dr Jonathan Parsons, The Ohio State University Asthma Center

Exercise-induced bronchoconstriction (EIB) guidelines: an interview with Dr Jonathan Parsons, The Ohio State University Asthma Center

Boehringer Ingelheim to highlight respiratory research work at ATS 2013

Boehringer Ingelheim to highlight respiratory research work at ATS 2013

Boehringer Ingelheim updates HCPs, patients on COMBIVENT RESPIMAT Inhalation Spray

Boehringer Ingelheim updates HCPs, patients on COMBIVENT RESPIMAT Inhalation Spray

Breo Ellipta gets FDA approval for treatment of airflow obstruction in patients with COPD

Breo Ellipta gets FDA approval for treatment of airflow obstruction in patients with COPD

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

Mylan gets final approval from FDA for generic Xopenex Inhalation Solution

Mylan gets final approval from FDA for generic Xopenex Inhalation Solution

Baxter files FEIBA NF BLA with FDA for prophylactic treatment of hemophilia A or B

Baxter files FEIBA NF BLA with FDA for prophylactic treatment of hemophilia A or B